Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Sham Innovation Sante
BioCentury | Oct 14, 2022
Finance
Oct. 14 Quick Takes: Sofinnova Partners, Mérieux back French ADC company Mablink
Plus Enliven finds path to NASDAQ via Imara deal and updates from Reata, Travere, Fujifilm, Inotrem, Obatala
BioCentury | Jul 21, 2021
Finance
French gene therapy play Coave rebrands with €21.2M series B extension
Formerly Horama, Coave is developing targeted therapies for CNS, ocular diseases
BioCentury | Jul 31, 2019
Financial News
Alizé seeks to build out company with largest European A round this year
Items per page:
1 - 7 of 7